{"id":"08c74e54-9390-559b-bfb7-c8d6290075cd","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-magnesium-combination-2016","predicate":"with_magnesium_associated_with_lower","statement":"The chromium-plus-magnesium group had lower fasting glucose, fasting insulin and the reported insulin-resistance index than its own baseline; the individual-treatment groups lacked significant within-group changes.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"87bec790-8200-560b-9adf-bcb6301fd886","mechanism_event_label":"The combination showed a signal in this trial, but comparing which groups reached significance does not by itself prove synergy.","subject":{"id":"1d98d864-31cb-5d4f-a587-2b0eb692faa0","slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"},"object":{"id":"06c0ed81-fa3d-5f04-ba87-469e7ed168ae","slug":"calculated-insulin-resistance-index","display_name":"Calculated insulin-resistance index (formula not verified)","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"87bec790-8200-560b-9adf-bcb6301fd886","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-magnesium-combination-2016-event","event_type":"observed_intervention","label":"The combination showed a signal in this trial, but comparing which groups reached significance does not by itself prove synergy.","description":"The chromium-plus-magnesium group had lower fasting glucose, fasting insulin and the reported insulin-resistance index than its own baseline; the individual-treatment groups lacked significant within-group changes.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"1f0c42f0-eaf3-5b86-966d-7ffc8a84872b","slug":"magnesium","display_name":"Magnesium","entity_type_key":"nutrient_element"},"role":"co_intervention","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"1d98d864-31cb-5d4f-a587-2b0eb692faa0","slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"06c0ed81-fa3d-5f04-ba87-469e7ed168ae","slug":"calculated-insulin-resistance-index","display_name":"Calculated insulin-resistance index (formula not verified)","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/chromium-research/27702717.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"5a066f8a51a4f0d4b33648166fc5bae559c5132e1ae35d65347c178359447d7e\", \"start_char\": 0, \"end_char\": 1556, \"text_sha256\": \"5a066f8a51a4f0d4b33648166fc5bae559c5132e1ae35d65347c178359447d7e\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Four-arm randomized supplementation study; 120 insulin-resistant adults","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Three months: chromium 160 µg/day, magnesium 200 mg/day, both, or placebo","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The abstract principally reports within-group changes, which alone do not establish a between-group interaction. T-lymphocyte mRNA is not skeletal-muscle transporter activity. Possible participant overlap with later reports is not resolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Chromium research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The combination showed a signal in this trial, but comparing which groups reached significance does not by itself prove synergy.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[chromium-p27702717] Combined chromium and magnesium decreases insulin resistance more effectively than either alone. (2016). https://pubmed.ncbi.nlm.nih.gov/27702717/ DOI: 10.6133/apjcn.092015.48","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Blood measures and activated T lymphocytes","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"249271b9-53f6-553f-8a05-089d054ad9b7","evidence_kind":"source_excerpt","locator":"Lines 562-573","start_line":562,"end_line":573,"excerpt":"### chromium-magnesium-combination-2016\nThe chromium-plus-magnesium group had lower fasting glucose, fasting insulin and the reported insulin-resistance index than its own baseline; the individual-treatment groups lacked significant within-group changes.\nCondition category: normal\nnutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The combination showed a signal in this trial, but comparing which groups reached significance does not by itself prove synergy.\norganism: Human\ntissue_or_cell_type: Blood measures and activated T lymphocytes\nexperimental_model: Four-arm randomized supplementation study; 120 insulin-resistant adults\nlimitations: The abstract principally reports within-group changes, which alone do not establish a between-group interaction. T-lymphocyte mRNA is not skeletal-muscle transporter activity. Possible participant overlap with later reports is not resolved.\nexposure: Three months: chromium 160 µg/day, magnesium 200 mg/day, both, or placebo\nevidence_span: {\"source_cache\": \"artifacts/chromium-research/27702717.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"5a066f8a51a4f0d4b33648166fc5bae559c5132e1ae35d65347c178359447d7e\", \"start_char\": 0, \"end_char\": 1556, \"text_sha256\": \"5a066f8a51a4f0d4b33648166fc5bae559c5132e1ae35d65347c178359447d7e\"}\n[chromium-p27702717] Combined chromium and magnesium decreases insulin resistance more effectively than either alone. (2016). https://pubmed.ncbi.nlm.nih.gov/27702717/ DOI: 10.6133/apjcn.092015.48","model_system":"Four-arm randomized supplementation study; 120 insulin-resistant adults","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [chromium-p27702717] Combined chromium and magnesium decreases insulin resistance more effectively than either alone. (2016). https://pubmed.ncbi.nlm.nih.gov/27702717/ DOI: 10.6133/apjcn.092015.48","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"fa96342a-ca01-5425-98d9-d50e29bf0abd","stable_key":"import-4d8e4781-3878-5818-8d0a-7dbd6e024555","title":"Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"6cae22f9104c6de041b25c23b0fd2884cc57707ac0c9a87c20b0e665d16de5ab","revision_id":"22893798-8329-5295-9c9d-82169032fc79","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}